In early gastric cancer, low expression of IL-2 and IL-17 is associated with a favorable prognosis, while in advanced gastric cancer, the expression of these cytokines does not significantly impact survival rates. It is speculated that they may influence the prognosis of gastric cancer at the time of onset. This evidence concerns the gene IL17A and gastric cancer.